Risk prediction of atrial fibrillation and its complications in the community using hs troponin I.
Christin S BörschelBastiaan GeelhoedTeemu NiiranenStephan CamenMaria Benedetta DonatiAki S HavulinnaFrancesco GianfagnaTarja TuovinenPekka JousilahtiJukka KonttoErkki VartiainenFrancisco M OjedaHester M den RuijterSimona CostanzoGiovanni de GaetanoAugusto Di CastelnuovoAllan LinnebergJulie K Vishram-NielsenMaja-Lisa LøchenWolfgang KoenigTorben JørgensenKari KuulasmaaStefan BlankenbergLicia IacovielloTanja ZellerStefan SöderbergVeikko SalomaaRenate B SchnabelPublished in: European journal of clinical investigation (2023)
hsTnI as a biomarker of myocardial injury does not improve prediction of AF incidence beyond classical CVRF and NT-proBNP. However, it is associated with the AF-related disease heart failure and mortality likely reflecting underlying subclinical cardiovascular impairment.
Keyphrases
- atrial fibrillation
- heart failure
- risk factors
- oral anticoagulants
- left atrial
- catheter ablation
- left atrial appendage
- direct oral anticoagulants
- healthcare
- mental health
- cardiovascular events
- percutaneous coronary intervention
- left ventricular
- cardiovascular disease
- acute heart failure
- type diabetes
- mitral valve
- acute coronary syndrome